14-16 For patients receiving either a GLP-1 RA or an SGLT2 inhibitor for CV risk reduction, the ADA recommends considering the addition of the other class if benefits outweigh risks (e.g., if already on a GLP-1 RA, add an SGLT2 inhibitor with proven CV benefit or vice versa) in addition to optimizing other guideline-directed medical therapies for prevention ( Figure 4 )
Particularly in dehydrated or fatigued patients
Henry Meds review covering semaglutide options, costs, and weight-loss vs
Limited evidence from research in men with type 2 diabetes and obesity suggests that weight loss and improved metabolic control associated with GLP-1 agonist therapy may correlate with improvements in erectile function and sexual satisfaction
What should I consider before using Semaglutide GLP-1 for weight loss
She could switch to an expensive branded medication or what she intends to do continue her treatment with a customized, clinically necessary compounded version of tirzepatide that meets stricter regulatory standards